Holocene Advisors’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Hold |
0
| – | – | – | 984 |
|
|
2022
Q2 | – | Sell |
-848,177
| Closed | -$69.7M | – | 1040 |
|
|
2022
Q1 | $69.7M | Sell |
848,177
-193,240
| -19% | -$15.9M | 0.36% | 85 |
|
|
2021
Q4 | $153M | Buy |
1,041,417
+248,024
| +31% | +$36.4M | 0.8% | 28 |
|
|
2021
Q3 | $140M | Buy |
793,393
+70,171
| +10% | +$12.4M | 0.76% | 26 |
|
|
2021
Q2 | $117M | Buy |
723,222
+414,251
| +134% | +$66.9M | 0.66% | 35 |
|
|
2021
Q1 | $52.9M | Sell |
308,971
-27,689
| -8% | -$4.74M | 0.33% | 96 |
|
|
2020
Q4 | $73.9M | Buy |
336,660
+69,978
| +26% | +$15.4M | 0.47% | 60 |
|
|
2020
Q3 | $44.3M | Sell |
266,682
-61,148
| -19% | -$10.2M | 0.34% | 87 |
|
|
2020
Q2 | $37.4M | Sell |
327,830
-76,849
| -19% | -$8.77M | 0.33% | 85 |
|
|
2020
Q1 | $31.1M | Buy |
404,679
+192,748
| +91% | +$14.8M | 0.33% | 91 |
|
|
2019
Q4 | $27.3M | Buy |
211,931
+105,207
| +99% | +$13.6M | 0.24% | 102 |
|
|
2019
Q3 | $8.32M | Buy |
+106,724
| New | +$8.32M | 0.09% | 130 |
|